Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Late-Breakers To Look Out For At ASCO 2020

Pfizer, Merck KGaA, Merck & Co, Amgen and AstraZeneca To Present

14 May 2020

• By Alexandra Shimmings

T-cells - lymphocytes — • Source: Shutterstock

Related Content

Amgen's Kyprolis Miss In First-Line Myeloma Surprising, But Clinically Irrelevant

27 Sep 2016

Myeloma Survival Benefit May Help Amgen's <em>Kyprolis</em> Stave Off Competition

01 Mar 2017

Related Companies

Pfizer Inc.

Merck KGaA

Merck & Co., Inc.

AstraZeneca PLC

Amgen, Inc.

Onyx Pharmaceuticals, Inc.

Additional Topics

Companies Clinical Trials ImmunoOncology Research & Development ASCO Cancer BioPharmaceutical

More from ASCO

More from Conferences

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.